SOBI•prnewswire•
Sobi to Showcase Scientific advances and Commitment to the Haemophilia community at EAHAD 2026
Summary
STOCKHOLM, Feb. 3, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced its participation at the 19th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), taking place 3-6 February 2026 in Dublin, Ireland. At this...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 3, 2026 by prnewswire